Chapter 2. Pharmaceutical Industry Status 295 4) Top Products by Function The total number of products that acquired the government permission increased by 505 to reach 16,061, and the total production value recorded KRW9 trillion and 670.1 billion after realizing an increase of 10.14% in 2005. Circulatory system drugs accounted for the biggest part of the whole at the value of KRW1 trillion 758 billion, closely followed by digestive system drugs at the value of KRW1 trillion 257.2 billion. The third biggest product group was antibiotic substances at the value of KRW1 trillion 227 billion. It was also noteworthy that “other drugs not primarily meant for medical treatment,” “tissue cell treatment/diagnostic drugs,” “other functional drugs for tissue cells,” and “artificial irrigation solutions” recorded a y-o-y growth of 30% or more in production.
296 2007 Korea Pharmaceutical Industry Directory Table Ⅱ-2-3 Pharmaceutical Production by Function (2003-2005) (Units, KRW1 Million) No. Functions ’03 Approved Items ’03 Production ’04 Approved Items ’04 Production ’05 Approved Items ’05 Production Growth (%) Total 15,302 8,013,005 15,556 8,779,520 16,061 9,670,051 10.14 100 210 Circulatory System Drugs 1,303 1,239,083 1,369 1,549,936 1,487 1,758,015 13.43 18.18 230 Digestive System Drugs 2,401 1,036,072 2,374 1,106,878 2,456 1,257,234 13.58 13.00 610 Antibiotic Substances 1,423 1,076,247 1,462 1,120,624 1,593 1,227,041 9.50 12.69 110 Central Nervous System Drugs 2,182 922,888 2,228 1,029,958 2,328 1,127,787 9.50 11.66 390 Other Metabolic Drugs 959 559,541 987 629,909 1,029 694,366 10.23 7.18 320 Dietary Supplements 843 522,990 823 522,139 850 512,206 -1.90 5.30 260 Drugs for External Use 952 345,974 975 358,976 988 397,845 10.83 4.11 620 Chemotherapeutics 439 316,681 481 365,735 525 387,365 5.91 4.01 630 Biological Drug Substances 80 304,730 78 309,200 73 307,874 -0.43 3.18 220 Respiratory System Drugs 854 224,714 880 239,270 828 257,489 7.61 2.66 310 Vitamins 598 228,048 623 240,922 602 247,049 2.54 2.55 330 Blood & Humoral Drugs 178 177,000 181 194,558 181 211,776 8.85 2.19 140 Anti-allergens 304 158,173 323 153,783 291 193,360 25.74 2.00 120 240 Peripheral Nervous System Drugs Hormones (inc. Anti-hormones) Weight (%) 570 160,386 594 168,583 604 191,687 13.70 1.98 235 158,189 234 155,198 231 180,027 16.00 1.86 720 Diagnostic Drugs 485 118,462 551 137,445 501 155,674 13.26 1.61 420 Tumor Treatment Drugs 207 109,782 208 121,215 202 134,501 10.96 1.39 250 Genitourinary & Proctology Drugs 351 115,383 318 100,304 353 113,776 13.43 1.18 130 Sensory System Drugs 306 77,507 278 81,491 316 104,094 27.74 1.08 340 Artificial Irrigation Solutions 37 44,280 35 55,471 40 73,092 31.77 0.76 740 Related Products 18 46,061 23 42,644 19 46,805 9.76 0.48 640 Parasite Drugs 95 31,616 84 49,123 83 37,520 -23.62 0.39 430 490 790 190 Tissue Cell Treatment/ Diagnostic Drugs Other Functional Drugs for Tissue Cells Other Drugs Not Primarily Meant for Medical Treatment Other Drugs for the Nervous & Sensory Systems 54 7,816 52 11,182 69 17,127 53.17 0.18 10 6,500 10 7,072 10 9,459 33.75 0.10 7 27,230 8 2,739 12 8,388 206.24 0.09 82 10,460 77 10,965 72 8,028 -26.79 0.08 710 Prescription Drugs 281 7,937 249 8,811 273 6,750 -23.39 0.07 730 Public Hygiene Drugs 23 3,033 29 4,456 23 3,035 -31.89 0.03 410 Tissue Recovery Agents 2 486 2 714 1 440 -38.38 0.00 290 Other Drugs for Different Organs 23 247 20 202 21 227 12.38 0.00 Source: Annual Food & Drug Statistics Report, Korea Food & Drug Administration, 2006.
- Page 2 and 3: 2007 Korea Pharmaceutical Industry
- Page 4 and 5: 2007 Korea Pharmaceutical Industry
- Page 6 and 7: 27. ILYANG PHARM ·········
- Page 8 and 9: Chapter 1. Outline of The Project 2
- Page 10 and 11: Chapter 1. Outline of The Project 2
- Page 12 and 13: Chapter 2. Pharmaceutical Industry
- Page 14 and 15: Chapter 2. Pharmaceutical Industry
- Page 16 and 17: Chapter 2. Pharmaceutical Industry
- Page 20 and 21: Chapter 2. Pharmaceutical Industry
- Page 22 and 23: Chapter 2. Pharmaceutical Industry
- Page 24 and 25: Chapter 2. Pharmaceutical Industry
- Page 26 and 27: Chapter 2. Pharmaceutical Industry
- Page 28 and 29: Chapter 2. Pharmaceutical Industry
- Page 30 and 31: Chapter 2. Pharmaceutical Industry
- Page 32 and 33: Chapter 2. Pharmaceutical Industry
- Page 34 and 35: Chapter 2. Pharmaceutical Industry
- Page 36 and 37: The Annex
- Page 38 and 39: 316 2007 Korea Pharmaceutical Indus
- Page 40 and 41: The Korean Pharmaceutical Company L
- Page 42 and 43: The Korean Pharmaceutical Company L
- Page 44 and 45: The Korean Pharmaceutical Company L
- Page 46 and 47: The Korean Pharmaceutical Company L
- Page 48 and 49: The Korean Pharmaceutical Company L
- Page 50 and 51: The Korean Pharmaceutical Company L
- Page 52 and 53: The Korean Pharmaceutical Company L
- Page 54 and 55: The Korean Pharmaceutical Company L
- Page 56 and 57: The Korean Pharmaceutical Company L
- Page 58 and 59: The Korean Pharmaceutical Company L
- Page 60 and 61: The Korean Pharmaceutical Company L
- Page 62 and 63: The Korean Pharmaceutical Company L
- Page 64 and 65: The Korean Pharmaceutical Company L
- Page 66 and 67: The Korean Pharmaceutical Company L
- Page 68 and 69:
The Korean Pharmaceutical Company L
- Page 70 and 71:
The Korean Pharmaceutical Company L
- Page 72 and 73:
4. Company Map The Korean Pharmace
- Page 74 and 75:
The Korean Pharmaceutical Company L
- Page 76 and 77:
The Korean Pharmaceutical Company L
- Page 78 and 79:
The Korean Pharmaceutical Company L
- Page 80 and 81:
The Korean Pharmaceutical Company L
- Page 82 and 83:
The Korean Pharmaceutical Company L
- Page 84 and 85:
The Korean Pharmaceutical Company L
- Page 86 and 87:
The Korean Pharmaceutical Company L
- Page 88 and 89:
5. Company Map The Korean Pharmace
- Page 90 and 91:
The Korean Pharmaceutical Company L
- Page 92 and 93:
5. Company Map The Korean Pharmace
- Page 94 and 95:
The Korean Pharmaceutical Company L
- Page 96 and 97:
The Korean Pharmaceutical Company L
- Page 98 and 99:
The Korean Pharmaceutical Company L
- Page 100 and 101:
The Korean Pharmaceutical Company L
- Page 102 and 103:
The Korean Pharmaceutical Company L
- Page 104 and 105:
The Korean Pharmaceutical Company L
- Page 106 and 107:
The Korean Pharmaceutical Company L
- Page 108 and 109:
The Korean Pharmaceutical Company L
- Page 110 and 111:
The Korean Pharmaceutical Company L
- Page 112 and 113:
The Korean Pharmaceutical Company L
- Page 114 and 115:
The Korean Pharmaceutical Company L
- Page 116 and 117:
The Korean Pharmaceutical Company L
- Page 118 and 119:
The Korean Pharmaceutical Company L
- Page 120 and 121:
The Korean Pharmaceutical Company L
- Page 122 and 123:
The Korean Pharmaceutical Company L
- Page 124 and 125:
The Korean Pharmaceutical Company L
- Page 126 and 127:
The Korean Pharmaceutical Company L
- Page 128 and 129:
The Korean Pharmaceutical Company L
- Page 130 and 131:
The Korean Pharmaceutical Company L
- Page 132 and 133:
The Korean Pharmaceutical Company L
- Page 134 and 135:
The Korean Pharmaceutical Company L
- Page 136 and 137:
The Korean Pharmaceutical Company L
- Page 138 and 139:
The Korean Pharmaceutical Company L
- Page 140 and 141:
The Korean Pharmaceutical Company L
- Page 142 and 143:
The Korean Pharmaceutical Company L
- Page 144 and 145:
The Korean Pharmaceutical Company L
- Page 146 and 147:
The Korean Pharmaceutical Company L
- Page 148 and 149:
The Korean Pharmaceutical Company L
- Page 150 and 151:
The Korean Pharmaceutical Company L
- Page 152 and 153:
The Korean Pharmaceutical Company L
- Page 154 and 155:
The Korean Pharmaceutical Company L
- Page 156 and 157:
The Korean Pharmaceutical Company L
- Page 158 and 159:
The Korean Pharmaceutical Company L
- Page 160 and 161:
The Korean Pharmaceutical Company L
- Page 162 and 163:
The Korean Pharmaceutical Company L
- Page 164 and 165:
The Korean Pharmaceutical Company L
- Page 166 and 167:
The Korean Pharmaceutical Company L
- Page 168 and 169:
The Korean Pharmaceutical Company L
- Page 170 and 171:
The Korean Pharmaceutical Company L
- Page 172 and 173:
The Korean Pharmaceutical Company L
- Page 174 and 175:
The Korean Pharmaceutical Company L
- Page 176 and 177:
The Korean Pharmaceutical Company L
- Page 178 and 179:
The Korean Pharmaceutical Company L
- Page 180 and 181:
The Korean Pharmaceutical Company L
- Page 182 and 183:
The Korean Pharmaceutical Company L
- Page 184 and 185:
The Korean Pharmaceutical Company L
- Page 186 and 187:
The Korean Pharmaceutical Company L
- Page 188 and 189:
The Korean Pharmaceutical Company L
- Page 190 and 191:
The Korean Pharmaceutical Company L
- Page 192 and 193:
The Korean Pharmaceutical Company L
- Page 194 and 195:
The Korean Pharmaceutical Company L
- Page 196 and 197:
The Korean Pharmaceutical Company L
- Page 198 and 199:
The Korean Pharmaceutical Company L
- Page 200 and 201:
4. Company Map The Korean Pharmace
- Page 202 and 203:
The Korean Pharmaceutical Company L
- Page 204 and 205:
The Korean Pharmaceutical Company L
- Page 206 and 207:
The Korean Pharmaceutical Company L
- Page 208 and 209:
The Korean Pharmaceutical Company L
- Page 210 and 211:
The Korean Pharmaceutical Company L
- Page 212 and 213:
The Korean Pharmaceutical Company L
- Page 214 and 215:
The Korean Pharmaceutical Company L
- Page 216 and 217:
The Korean Pharmaceutical Company L
- Page 218 and 219:
The Korean Pharmaceutical Company L
- Page 220 and 221:
The Korean Pharmaceutical Company L
- Page 222 and 223:
The Korean Pharmaceutical Company L
- Page 224 and 225:
The Korean Pharmaceutical Company L
- Page 226 and 227:
The Korean Pharmaceutical Company L
- Page 228 and 229:
The Korean Pharmaceutical Company L
- Page 230 and 231:
The Korean Pharmaceutical Company L
- Page 232 and 233:
The Korean Pharmaceutical Company L
- Page 234 and 235:
The Korean Pharmaceutical Company L
- Page 236 and 237:
The Korean Pharmaceutical Company L
- Page 238 and 239:
The Korean Pharmaceutical Company L
- Page 240 and 241:
The Korean Pharmaceutical Company L
- Page 242 and 243:
The Korean Pharmaceutical Company L
- Page 244 and 245:
The Korean Pharmaceutical Company L
- Page 246 and 247:
The Korean Pharmaceutical Company L
- Page 248 and 249:
The Korean Pharmaceutical Company L
- Page 250 and 251:
The Korean Pharmaceutical Company L
- Page 252 and 253:
The Korean Pharmaceutical Company L
- Page 254 and 255:
3. Company Map The Korean Pharmace
- Page 256 and 257:
The Korean Pharmaceutical Company L
- Page 258 and 259:
The Korean Pharmaceutical Company L
- Page 260 and 261:
The Korean Pharmaceutical Company L
- Page 262 and 263:
5. Company Map The Korean Pharmace
- Page 264 and 265:
The Korean Pharmaceutical Company L
- Page 266 and 267:
The Korean Pharmaceutical Company L
- Page 268 and 269:
The Korean Pharmaceutical Company L
- Page 270 and 271:
5. Company Map The Korean Pharmace